Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 tat protein

Journal of Virology

Volumn 88, Issue 16, 2014, Pages 8924-8935

  Gonzalez Hernandez, Marta J ^a,b   Cavalcoli, James D ^a   Sartor, Maureen A ^a,b   Contreras Galindo, Rafael ^a   Meng, Fan ^a,c   Dai, Manhong ^a,c   Dube, Derek ^a   Saha, Anjan K ^a   Gitlin, Scott D ^a,b   Omenn, Gilbert S ^a,b   Kaplan, Mark H ^a   Markovitz, David M ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSACTIVATOR PROTEIN; TRANSCRIPTOME; VIRUS RNA;

ARTICLE; BLOOD DONOR; ENDOGENOUS RETROVIRUS; FEMALE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN ENDOGENOUS RETROVIRUS TYPE K; HUMAN IMMUNODEFICIENCY VIRUS 1; NEXT GENERATION SEQUENCING; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROVIRUS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; RNA SEQUENCE;

CELLS, CULTURED; ENDOGENOUS RETROVIRUSES; GENE PRODUCTS, TAT; GENOME, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTES; PROVIRUSES; RNA, VIRAL; TRANSCRIPTOME; VIRAL PROTEINS;

EID: 84904871470     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00556-14     Document Type: Article

References (88)

1. Gifford R, Tristem M. 2003. The evolution, distribution and diversity of endogenous retroviruses. Virus Genes 26:291-315. http://dx.doi.org/10.1023/A:1024455415443.
2. Feschotte C, Gilbert C. 2012. Endogenous viruses: insights into viral evolution and impact on host biology. Nat. Rev. Genet. 13:283-296. http://dx.doi.org/10.1038/nrg3199.
3. Jern P, Coffin JM. 2008. Effects of retroviruses on host genome function. Annu. Rev. Genet. 42:709-732. http://dx.doi.org/10.1146/annurev.genet.42.110807.091501.
4. Bannert N, Kurth R. 2006. The evolutionary dynamics of human endogenous retroviral families. Annu. Rev. Genomics Hum. Genet. 7:149-173. http://dx.doi.org/10.1146/annurev.genom.7.080505.115700.
5. Belshaw R, Pereira V, Katzourakis A, Talbot G, Paces J, Burt A, Tristem M. 2004. Long-term reinfection of the human genome by endogenous retroviruses. Proc. Natl. Acad. Sci. U. S. A. 101:4894-4899. http://dx.doi.org/10.1073/pnas.0307800101.
6. Bannert N, Kurth R. 2004. Retroelements and the human genome: new perspectives on an old relation. Proc. Natl. Acad. Sci. U. S. A. 101(Suppl 2):S14572-S14579. http://dx.doi.org/10.1073/pnas.0404838101.
7. Flockerzi A, Ruggieri A, Frank O, Sauter M, Maldener E, Kopper B, Wullich B, Seifarth W, Muller-Lantzsch N, Leib-Mosch C, Meese E, Mayer J. 2008. Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV transcriptome project. BMC Genomics 9:354. http://dx.doi.org/10.1186/1471-2164-9-354.
8. Berkhout B, Jebbink M, Zsiros J. 1999. Identification of an active reverse transcriptase enzyme encoded by a human endogenous HERV-K retrovirus. J. Virol. 73:2365-2375.
9. Subramanian RP, Wildschutte JH, Russo C, Coffin JM. 2011. Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses. Retrovirology 8:90. http://dx.doi.org/10.1186/1742-4690-8-90.
10. Turner G, Barbulescu M, Su M, Jensen-Seaman MI, Kidd KK, Lenz J. 2001. Insertional polymorphisms of full-length endogenous retroviruses in humans. Curr. Biol. 11:1531-1535. http://dx.doi.org/10.1016/S0960-9822(01)00455-9.
11. Barbulescu M, Turner G, Seaman MI, Deinard AS, Kidd KK, Lenz J. 1999. Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. Curr. Biol. 9:861-868. http://dx.doi.org/10.1016/S0960-9822(99)80390-X.
12. Mayer J, Sauter M, Racz A, Scherer D, Mueller-Lantzsch N, Meese E. 1999. An almost-intact human endogenous retrovirus K on human chromosome 7. Nat. Genet. 21:257-258. http://dx.doi.org/10.1038/6766.
13. Armbruester V, Sauter M, Krautkraermer E, Meese E, Kleiman A, Best B, Roemer K, Mueller-Lantzsch N. 2002. A novel gene from the human endogenous retrovirus K expressed in transformed cells. Clin. Cancer Res. 8:1800-1807.
14. Buscher K, Hahn S, Hofmann M, Trefzer U, Ozel M, Sterry W, Lower J, Lower R, Kurth R, Denner J. 2006. Expression of the human endogenous retrovirus-K transmembrane envelope, Rec and Np9 proteins in melanomas and melanoma cell lines. Melanoma Res. 16:223-234. http://dx.doi.org/10.1097/01.cmr.0000215031.07941.ca.
15. Boese A, Sauter M, Galli U, Best B, Herbst H, Mayer J, Kremmer E, Roemer K, Mueller-Lantzsch N. 2000. Human endogenous retrovirus protein cORF supports cell transformation and associates with the promyelocytic leukemia zinc finger protein. Oncogene 19:4328-4336. http://dx.doi.org/10.1038/sj.onc.1203794.
16. Galli UM, Sauter M, Lecher B, Maurer S, Herbst H, Roemer K, Mueller-Lantzsch N. 2005. Human endogenous retrovirus rec interferes with germ cell development in mice and may cause carcinoma in situ, the predecessor lesion of germ cell tumors. Oncogene 24:3223-3228. http://dx.doi.org/10.1038/sj.onc.1208543.
17. Buscher K, Trefzer U, Hofmann M, Sterry W, Kurth R, Denner J. 2005. Expression of human endogenous retrovirus K in melanomas and melanoma cell lines. Cancer Res. 65:4172-4180. http://dx.doi.org/10.1158/0008-5472.CAN-04-2983.
18. Krieg AM, Gourley MF, Klinman DM, Perl A, Steinberg AD. 1992. Heterogeneous expression and coordinate regulation of endogenous retroviral sequences in human peripheral blood mononuclear cells. AIDS Res. Hum. Retrovir. 8:1991-1998. http://dx.doi.org/10.1089/aid.1992.8.1991.
19. Medstrand P, Lindeskog M, Blomberg J. 1992. Expression of human endogenous retroviral sequences in peripheral blood mononuclear cells of healthy individuals. J. Gen. Virol. 73(Part 9):2463-2466. http://dx.doi.org/10.1099/0022-1317-73-9-2463.
20. Brodsky I, Foley B, Haines D, Johnston J, Cuddy K, Gillespie D. 1993. Expression of HERV-K proviruses in human leukocytes. Blood 81:2369-2374.
21. Tonjes RR, Lower R, Boller K, Denner J, Hasenmaier B, Kirsch H, Konig H, Korbmacher C, Limbach C, Lugert R, Phelps RC, Scherer J, Thelen K, Lower J, Kurth R. 1996. HERV-K: the biologically most active human endogenous retrovirus family. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13(Suppl 1):S261-S267. http://dx.doi.org/10.1097/00042560-199600001-00039.
22. Blomberg JMP, Yin H, Andersson ML, Lindeskog M, Borg A, Olsson H. 1995. Expression of human endogenous retroviral sequences: differences between individuals and cell types. Increased expression in a human breast cancer. J. Cancer Res. Clin. Oncol. 121:3.
23. Paces J, Huang YT, Paces V, Ridl J, Chang CM. 2012. New insight into transcription of human endogenous retroviral elements. N. Biotechnol. 30:314-318. http://dx.doi.org/10.1016/j.nbt.2012.11.009.
24. Moyes DL, Martin A, Sawcer S, Temperton N, Worthington J, Griffiths DJ, Venables PJ. 2005. The distribution of the endogenous retroviruses HERV-K113 and HERV-K115 in health and disease. Genomics 86:337-341. http://dx.doi.org/10.1016/j.ygeno.2005.06.004.
25. Gourley MF, Kisch WJ, Mojcik CF, King LB, Krieg AM, Steinberg AD. 1994. Role of endogenous retroviruses in autoimmune diseases. Tohoku J. Exp. Med. 173:105-114. http://dx.doi.org/10.1620/tjem.173.105.
26. Bieda K, Hoffmann A, Boller K. 2001. Phenotypic heterogeneity of human endogenous retrovirus particles produced by teratocarcinoma cell lines. J. Gen. Virol. 82:591-596.
27. Seifarth W, Frank O, Zeilfelder U, Spiess B, Greenwood AD, Hehlmann R, Leib-Mosch C. 2005. Comprehensive analysis of human endogenous retrovirus transcriptional activity in human tissues with a retrovirus specific microarray. J. Virol. 79:341-352. http://dx.doi.org/10.1128/JVI.79.1.341-352.2005.
28. Okahara G, Matsubara S, Oda T, Sugimoto J, Jinno Y, Kanaya F. 2004. Expression analyses of human endogenous retroviruses (HERVs): tissuespecific and developmental stage-dependent expression of HERVs. Genomics 84:982-990. http://dx.doi.org/10.1016/j.ygeno.2004.09.004.
29. La Mantia G, Maglione D, Pengue G, Di Cristofano A, Simeone A, Lanfrancone L, Lania L. 1991. Identification and characterization of novel human endogenous retroviral sequences preferentially expressed in undifferentiated embryonal carcinoma cells. Nucleic Acids Res. 19:1513-1520. http://dx.doi.org/10.1093/nar/19.7.1513.
30. Hsiao FC, Lin M, Tai A, Chen G, Huber BT. 2006. Cutting edge: Epstein-Barr virus transactivates the HERV-K18 superantigen by docking to the human complement receptor 2 (CD21) on primary B cells. J. Immunol. 177:2056-2060. http://dx.doi.org/10.4049/jimmunol.177.4.2056.
31. Tai AK, Luka J, Ablashi D, Huber BT. 2009. HHV-6A infection induces expression of HERV-K18-encoded superantigen. J. Clin. Virol. 46:47-48. http://dx.doi.org/10.1016/j.jcv.2009.05.019.
32. Turcanova VL, Bundgaard B, Hollsberg P. 2009. Human herpesvirus-6B induces expression of the human endogenous retrovirus K18-encoded superantigen. J. Clin. Virol. 46:15-19. http://dx.doi.org/10.1016/j.jcv.2009.05.015.
33. Contreras-Galindo R, Lopez P, Velez R, Yamamura Y. 2007. HIV-1 infection increases the expression of human endogenous retroviruses type K (HERV-K) in vitro. AIDS Res. Hum. Retrovir. 23:116-122. http://dx.doi.org/10.1089/aid.2006.0117.
34. Kwun HJ, Han HJ, Lee WJ, Kim HS, Jang KL. 2002. Transactivation of the human endogenous retrovirus K long terminal repeat by herpes simplex virus type 1 immediate early protein 0. Virus Res. 86:93-100. http://dx.doi.org/10.1016/S0168-1702(02)00058-8.
35. Chu WM, Ballard R, Carpick BW, Williams BR, Schmid CW. 1998. Potential Alu function: regulation of the activity of double-stranded RNAactivated kinase PKR. Mol. Cell. Biol. 18:58-68.
36. Jang KL, Collins MK, Latchman DS. 1992. The human immunodeficiency virus tat protein increases the transcription of human Alu repeated sequences by increasing the activity of the cellular transcription factor TFIIIC. J. Acquir. Immune Defic. Syndr. 5:1142-1147.
37. Katsumata K, Ikeda H, Sato M, Ishizu A, Kawarada Y, Kato H, Wakisaka A, Koike T, Yoshiki T. 1999. Cytokine regulation of env gene expression of human endogenous retrovirus-R in human vascular endothelial cells. Clin. Immunol. 93:75-80. http://dx.doi.org/10.1006/clim.1999.4762.
38. Ono M, Kawakami M, Ushikubo H. 1987. Stimulation of expression of the human endogenous retrovirus genome by female steroid hormones in human breast cancer cell line T47D. J. Virol. 61:2059-2062.
39. Hohenadl C, Germaier H, Walchner M, Hagenhofer M, Herrmann M, Sturzl M, Kind P, Hehlmann R, Erfle V, Leib-Mosch C. 1999. Transcriptional activation of endogenous retroviral sequences in human epidermal keratinocytes by UVB irradiation. J. Investig. Dermatol. 113:587-594. http://dx.doi.org/10.1046/j.1523-1747.1999.00728.x.
40. Khan AS, Muller J, Sears JF. 2001. Early detection of endogenous retroviruses in chemically induced mouse cells. Virus Res. 79:39-45. http://dx.doi.org/10.1016/S0168-1702(01)00280-5.
41. Reiche J, Pauli G, Ellerbrok H. 2010. Differential expression of human endogenous retrovirus K transcripts in primary human melanocytes and melanoma cell lines after UV irradiation. Melanoma Res. 20:435-440. http://dx.doi.org/10.1097/CMR.0b013e32833c1b5d.
42. Evans LH, Alamgir AS, Owens N, Weber N, Virtaneva K, Barbian K, Babar A, Malik F, Rosenke K. 2009. Mobilization of endogenous retroviruses in mice after infection with an exogenous retrovirus. J. Virol. 83: 2429-2435. http://dx.doi.org/10.1128/JVI.01926-08.
43. Takeda S, Sugimoto K, Otsuki H, Hirochika H. 1998. Transcriptional activation of the tobacco retrotransposon Tto1 by wounding and methyl jasmonate. Plant Mol. Biol. 36:365-376. http://dx.doi.org/10.1023/A:1005911413528.
44. Toufaily C, Landry S, Leib-Mosch C, Rassart E, Barbeau B. 2011. Activation of LTRs from different human endogenous retrovirus (HERV) families by the HTLV-1 tax protein and T-cell activators. Viruses 3:2146-2159. http://dx.doi.org/10.3390/v3112146.
45. Contreras-Galindo R, Kaplan MH, Contreras-Galindo AC, Gonzalez-Hernandez MJ, Ferlenghi I, Giusti F, Lorenzo E, Gitlin SD, Dosik MH, Yamamura Y, Markovitz DM. 2012. Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals. J. Virol. 86:262-276. http://dx.doi.org/10.1128/JVI.00602-11.
46. Gonzalez-Hernandez MJ, Swanson MD, Contreras-Galindo R, Cookinham S, King SR, Noel RJ, Jr, Kaplan MH, Markovitz DM. 2012. Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1. J. Virol. 86:7790-7805. http://dx.doi.org/10.1128/JVI.07215-11.
47. Contreras-Galindo R, Almodovar-Camacho S, Gonzalez-Ramirez S, Lorenzo E, Yamamura Y. 2007. Comparative longitudinal studies of HERV-K and HIV-1 RNA titers in HIV-1-infected patients receiving successful versus unsuccessful highly active antiretroviral therapy. AIDS Res. Hum. Retrovir. 23:1083-1086. http://dx.doi.org/10.1089/aid.2007.0054.
48. Contreras-Galindo R, Gonzalez M, Almodovar-Camacho S, Gonzalez-Ramirez S, Lorenzo E, Yamamura Y. 2006. A new real-time-RT-PCR for quantitation of human endogenous retroviruses type K (HERV-K) RNA load in plasma samples: increased HERV-K RNA titers in HIV-1 patients with HAART non-suppressive regimens. J. Virol. Methods 136:51-57. http://dx.doi.org/10.1016/j.jviromet.2006.03.029.
49. Contreras-Galindo R, Kaplan MH, Leissner P, Verjat T, Ferlenghi I, Bagnoli F, Giusti F, Dosik MH, Hayes DF, Gitlin SD, Markovitz DM. 2008. Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer. J. Virol. 82:9329-9336. http://dx.doi.org/10.1128/JVI.00646-08.
50. Contreras-Galindo R, Kaplan MH, Markovitz DM, Lorenzo E, Yamamura Y. 2006. Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals. AIDS Res. Hum. Retrovir. 22:979-984. http://dx.doi.org/10.1089/aid.2006.22.979.
51. van der Kuyl AC. 2012. HIV infection and HERV expression: a review. Retrovirology 9:6. http://dx.doi.org/10.1186/1742-4690-9-6.
52. Jones RB, Garrison KE, Mujib S, Mihajlovic V, Aidarus N, Hunter DV, Martin E, John VM, Zhan W, Faruk NF, Gyenes G, Sheppard NC, Priumboom-Brees IM, Goodwin DA, Chen L, Rieger M, Muscat-King S, Loudon PT, Stanley C, Holditch SJ, Wong JC, Clayton K, Duan E, Song H, Xu Y, Sengupta D, Tandon R, Sacha JB, Brockman MA, Benko E, Kovacs C, Nixon DF, Ostrowski MA. 2012. HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates. J. Clin. Investig. 122: 4473-4489. http://dx.doi.org/10.1172/JCI64560.
53. Jones RB, John VM, Hunter DV, Martin E, Mujib S, Mihajlovic V, Burgers PC, Luider TM, Gyenes G, Sheppard NC, Sengupta D, Tandon R, Yue FY, Benko E, Kovacs C, Nixon DF, Ostrowski MA. 2012. Human endogenous retrovirus K(HML-2) Gag-and Env-specific T-cell responses are infrequently detected in HIV-1-infected subjects using standard peptide matrix-based screening. Clin. Vaccine Immunol. 19:288-292. http://dx.doi.org/10.1128/CVI.05583-11.
54. Freimanis G, Hooley P, Ejtehadi HD, Ali HA, Veitch A, Rylance PB, Alawi A, Axford J, Nevill A, Murray PG, Nelson PN. 2010. A role for human endogenous retrovirus-K (HML-2) in rheumatoid arthritis: investigating mechanisms of pathogenesis. Clin. Exp. Immunol. 160:340-347. http://dx.doi.org/10.1111/j.1365-2249.2010.04110.x.
55. Antony JM, Deslauriers AM, Bhat RK, Ellestad KK, Power C. 2011. Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants? Biochim. Biophys. Acta 1812:162-176. http://dx.doi.org/10.1016/j.bbadis.2010.07.016.
56. Nelson PN, Carnegie PR, Martin J, Davari Ejtehadi H, Hooley P, Roden D, Rowland-Jones S, Warren P, Astley J, Murray PG. 2003. Demystified. Human endogenous retroviruses. Mol. Pathol. 56:11-18. http://dx.doi.org/10.1136/mp.56.1.11.
57. Ehlhardt S, Seifert M, Schneider J, Ojak A, Zang KD, Mehraein Y. 2006. Human endogenous retrovirus HERV-K(HML-2) Rec expression and transcriptional activities in normal and rheumatoid arthritis synovia. J. Rheumatol. 33:16-23.
58. Sekigawa I, Ogasawara H, Kaneko H, Hishikawa T, Hashimoto H. 2001. Retroviruses and autoimmunity. Intern. Med. 40:80-86. http://dx.doi.org/10.2169/internalmedicine.40.80.
59. Herrmann M, Neidhart M, Gay S, Hagenhofer M, Kalden JR. 1998. Retrovirus-associated rheumatic syndromes. Curr. Opin. Rheumatol. 10: 347-354. http://dx.doi.org/10.1097/00002281-199807000-00012.
60. Löwer R, Löwer J, Kurth R. 1996. The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc. Natl. Acad. Sci. U. S. A. 93:5177-5184. http://dx.doi.org/10.1073/pnas.93.11.5177.
61. Singh S, Kaye S, Francis N, Peston D, Gore M, McClure M, Bunker C. 2013. Human endogenous retrovirusK(HERV-K) recmRNAis expressed in primary melanoma but not in benign naevi or normal skin. Pigment Cell Melanoma Res. 26:426-428. http://dx.doi.org/10.1111/pcmr.12066.
62. Armbruester V, Sauter M, Roemer K, Best B, Hahn S, Nty A, Schmid A, Philipp S, Mueller A, Mueller-Lantzsch N. 2004. Np9 protein of human endogenous retrovirus K interacts with ligand of numb protein X. J. Virol. 78:10310-10319. http://dx.doi.org/10.1128/JVI.78.19.10310-10319.2004.
63. Denne M, Sauter M, Armbruester V, Licht JD, Roemer K, Mueller-Lantzsch N. 2007. Physical and functional interactions of human endogenous retrovirus proteins Np9 and rec with the promyelocytic leukemia zinc finger protein. J. Virol. 81:5607-5616. http://dx.doi.org/10.1128/JVI.02771-06.
64. Kaufmann S, Sauter M, Schmitt M, Baumert B, Best B, Boese A, Roemer K, Mueller-Lantzsch N. 2010. Human endogenous retrovirus protein Rec interacts with the testicular zinc-finger protein and androgen receptor. J. Gen. Virol. 91:1494-1502. http://dx.doi.org/10.1099/vir.0.014241-0.
65. Chen T, Meng Z, Gan Y, Wang X, Gu Y, Xu X, Tang J, Zhou H, Zhang X, Gan X, Van Ness C, Xu F, Xu G, Huang L, Fang Y, Wu J, Zheng S, Jin J, Huang W, Xu R. 2013. The viral oncogene Np9 acts as a critical molecular switch for co-activating beta-catenin, ERK, Akt and Notch1 and promoting the growth of human leukemia stem/progenitor cells. Leukemia 27:1469-1478. http://dx.doi.org/10.1038/leu.2013.8.
66. Swanson MD, Winter HC, Goldstein IJ, Markovitz DM. 2010. A lectin isolated from bananas is a potent inhibitor of HIV replication. J. Biol. Chem. 285:8646-8655. http://dx.doi.org/10.1074/jbc.M109.034926.
67. Bohan CA, Kashanchi F, Ensoli B, Buonaguro L, Boris-Lawrie KA, Brady JN. 1992. Analysis of Tat transactivation of human immunodeficiency virus transcription in vitro. Gene Expr. 2:391-407.
68. Trapnell C, Pachter L, Salzberg SL. 2009. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25:1105-1111. http://dx.doi.org/10.1093/bioinformatics/btp120.
69. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, Pimentel H, Salzberg SL, Rinn JL, Pachter L. 2012. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7:562-578. http://dx.doi.org/10.1038/nprot.2012.016.
70. Quinlan AR, Hall IM. 2010. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26:841-842. http://dx.doi.org/10.1093/bioinformatics/btq033.
71. Farre D, Roset R, Huerta M, Adsuara JE, Rosello L, Alba MM, Messeguer X. 2003. Identification of patterns in biological sequences at the ALGGEN server:PROMOand MALGEN. Nucleic Acids Res. 31:3651-3653. http://dx.doi.org/10.1093/nar/gkg605.
72. Messeguer X, Escudero R, Farre D, Nunez O, Martinez J, Alba MM. 2002. PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 18:333-334. http://dx.doi.org/10.1093/bioinformatics/18.2.333.
73. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. 2008. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5:621-628. http://dx.doi.org/10.1038/nmeth.1226.
74. Newcombe RG. 1998. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat. Med. 17:873-890. http://dx.doi.org/10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I.
75. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. 57:289-300.
76. Jha AR, Pillai SK, York VA, Sharp ER, Storm EC, Wachter DJ, Martin JN, Deeks SG, Rosenberg MG, Nixon DF, Garrison KE. 2009. Crosssectional dating of novel haplotypes of HERV-K 113 and HERV-K 115 indicate these proviruses originated in Africa before Homo sapiens. Mol. Biol. Evol. 26:2617-2626. http://dx.doi.org/10.1093/molbev/msp180.
77. Dewannieux M, Blaise S, Heidmann T. 2005. Identification of a functional envelope protein from the HERV-K family of human endogenous retroviruses. J. Virol. 79:15573-15577. http://dx.doi.org/10.1128/JVI.79.24.15573-15577.2005.
78. Mayer J, Stuhr T, Reus K, Maldener E, Kitova M, Asmus F, Meese E. 2005. Haplotype analysis of the human endogenous retrovirus locus HERV-K(HML-2.HOM) and its evolutionary implications. J. Mol. Evol. 61:706-715. http://dx.doi.org/10.1007/s00239-005-0066-7.
79. Dewannieux M, Harper F, Richaud A, Letzelter C, Ribet D, Pierron G, Heidmann T. 2006. Identification of an infectious progenitor for the multiple-copy HERV-K human endogenous retroelements. Genome Res. 16:1548-1556. http://dx.doi.org/10.1101/gr.5565706.
80. Boller K, Schonfeld K, Lischer S, Fischer N, Hoffmann A, Kurth R, Tonjes RR. 2008. Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles. J. Gen. Virol. 89:567-572. http://dx.doi.org/10.1099/vir.0.83534-0.
81. Coiras M, Camafeita E, Urena T, Lopez JA, Caballero F, Fernandez B, Lopez-Huertas MR, Perez-Olmeda M, Alcami J. 2006. Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. Proteomics 6(Suppl 1):S63-S73. http://dx.doi.org/10.1002/pmic.200500437.
82. Pocernich CB, Poon HF, Boyd-Kimball D, Lynn BC, Nath A, Klein JB, Butterfield DA. 2005. Proteomic analysis of oxidatively modified proteins induced by the mitochondrial toxin 3-nitropropionic acid in human astrocytes expressing the HIV protein tat. Brain Res. Mol. Brain Res. 133: 299-306. http://dx.doi.org/10.1016/j.molbrainres.2004.10.024.
83. Poggi A, Carosio R, Spaggiari GM, Fortis C, Tambussi G, Dell'Antonio G, Dal Cin E, Rubartelli A, Zocchi MR. 2002. NK cell activation by dendritic cells is dependent on LFA-1-mediated induction of calciumcalmodulin kinase II: inhibition by HIV-1 Tat C-terminal domain. J. Immunol. 168:95-101. http://dx.doi.org/10.4049/jimmunol.168.1.95.
84. Rautonen N, Rautonen J, Martin NL, Wara DW. 1994. HIV-1 Tat induces cytokine synthesis by uninfected mononuclear cells. AIDS 8:1504-1506. http://dx.doi.org/10.1097/00002030-199410000-00023.
85. Contreras-Galindo R, Kaplan MH, He S, Contreras-Galindo AC, Gonzalez-Hernandez MJ, Kappes F, Dube D, Chan SM, Robinson D, Meng F, Dai M, Gitlin SD, Chinnaiyan AM, Omenn GS, Markovitz DM. 2013. HIV infection reveals widespread expansion of novel centromeric human endogenous retroviruses. Genome Res. 23:1505-1513. http://dx.doi.org/10.1101/gr.144303.112.
86. Illarionova AE, Vinogradova TV, Sverdlov ED. 2007. Only those genes of the KIAA1245 gene subfamily that contain HERV(K) LTRs in their introns are transcriptionally active. Virology 358:39-47. http://dx.doi.org/10.1016/j.virol.2006.06.027.
87. Dunham I, Kundaje A, Aldred SF, Collins PJ, Davis CA, Doyle F, Epstein CB, Frietze S, Harrow J, Kaul R, Khatun J, Lajoie BR, Landt SG, Lee BK, Pauli F, Rosenbloom KR, Sabo P, Safi A, Sanyal A, Shoresh N, Simon JM, Song L, Trinklein ND, Altshuler RC, Birney E, Brown JB, Cheng C, Djebali S, Dong X, Ernst J, Furey TS, Gerstein M, Giardine B, Greven M, Hardison RC, Harris RS, Herrero J, Hoffman MM, Iyer S, Kelllis M, Kheradpour P, Lassmann T, Li Q, Lin X, Marinov GK, Merkel A, Mortazavi A, Parker SC, Reddy TE, Rozowsky J, Schlesinger F, Thurman RE, Wang J, et al. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489:57-74. http://dx.doi.org/10.1038/nature11247.
88. Sanyal A, Lajoie BR, Jain G, Dekker J. 2012. The long-range interaction landscape of gene promoters. Nature 489:109-113. http://dx.doi.org/10.1038/nature11279.